CS logo
small CS logo
Centro de Estudios Reumatologicos

Santiago, Chile
Rheumatologist in Providencia, Chile
Av. Salvador 960, Providencia, Región Metropolitana

About Centro de Estudios Reumatologicos


"Consulta Reumatologica"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
Bristol-Myers Squibb
2
EMD Serono
2
EMD Serono Research & Development Institute, Inc.
2
Boehringer Ingelheim
1
Genentech, Inc.
1
Hoffmann-La Roche
1
Total Rows: 7

Clinical Trials at Centro de Estudios Reumatologicos


During the past decade, Centro de Estudios Reumatologicos conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 12 clinical trials were completed, i.e. on average, 240% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years220033000044Started TrialsCompleted Trails2015201620170246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
2007-02-05
2017-10-26
Completed
4,488
Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX
2010-01-01
2013-03-01
Completed
956
A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
2011-08-02
2016-03-25
Completed
3,080
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
2011-12-01
2014-03-01
Completed
183
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
2013-12-01
2016-09-01
Completed
306
Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)
2014-07-29
2018-02-09
Terminated
253
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
2015-01-26
2016-10-18
Completed
645
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
2014-11-13
2017-11-30
Completed
730

Rows per page:

1–12 of 12

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Centro de Estudios Reumatologicos" #1 sponsor was "Pfizer" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "EMD Serono" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Estudios Reumatologicos" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 3Pfizer: 3Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2EMD Serono: 2EMD Serono: 2EMD Serono Research &Development Institute,Inc.: 2EMD Serono Research &Development Institute,Inc.: 2Boehringer Ingelheim: 1Boehringer Ingelheim: 1Genentech, Inc.: 1Genentech, Inc.: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1

Created with Highcharts 11.1.0Top CollaboratorsMerck KGaA,Darmstadt, Germany: 2Merck KGaA,Darmstadt, Germany: 2

Clinical Trials Conditions at Centro de Estudios Reumatologicos


According to Clinical.Site data, the most researched conditions in "Centro de Estudios Reumatologicos" are "Arthritis, Rheumatoid" (3 trials), "Lupus Erythematosus, Systemic" (3 trials), "Rheumatoid Arthritis" (3 trials), "Systemic Lupus Erythematosus" (2 trials) and "Lupus" (1 trials). Many other conditions were trialed in "Centro de Estudios Reumatologicos" in a lesser frequency.

Clinical Trials Intervention Types at Centro de Estudios Reumatologicos


Most popular intervention types in "Centro de Estudios Reumatologicos" are "Drug" (11 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Atacicept 150 mg" (2 trials), "CP-690,550" (2 trials), "Abatacept" (1 trials) and "Abatacept Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Centro de Estudios Reumatologicos


The vast majority of trials in "Centro de Estudios Reumatologicos" are 12 trials for "All" genders.

Clinical Trials Status at Centro de Estudios Reumatologicos


Currently, there are NaN active trials in "Centro de Estudios Reumatologicos". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Centro de Estudios Reumatologicos, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Centro de Estudios Reumatologicos, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 7Phase 2: 7Phase 3: 4Phase 3: 4Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 10Completed: 10Terminated: 2Terminated: 2